When people ask me what I do at CIRM I sometimes half-jokingly tell them that I’m the official translator: I take complex science and turn it into everyday English. That’s important. The taxpayers of California have a right to know how their money is being spent and how it might benefit them. But that message … Continue reading Explaining COVID can be a pitch
Dr. Helen Blau
Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
Dr. Jianhua Yu (left), Dr. Helen Blau (center), and Dr. Albert Wong (right) COVID‑19 targets many parts of the body, often with serious or life‑threatening effects. This past Friday, the CIRM Board approved investments in three early‑stage research projects that take new approaches to treating the virus. City of Hope Dr. Jianhua Yu at the … Continue reading Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
Spotlight on Muscular Dystrophy and Stem Cell Research
In our latest video, “Spotlight on Muscular Dystrophy and Stem Cell Research” CIRM grantee and Stanford scientist Helen Blau illustrates new methods of modeling to more accurately map how a therapy might work in humans. Dr. Blau studies Duchenne muscular dystrophy (DMD), the most severe form of muscular dystrophy that affects 1 in 3500 boys … Continue reading Spotlight on Muscular Dystrophy and Stem Cell Research
Muscle stem cells a step closer to treating muscular dystrophy
Stanford scientists have overcome a major hurdle in developing therapies for treating muscular dystrophy and other muscle‑wasting diseases. Until now, muscle stem cells could not grow outside their natural environment. Once removed from muscle tissue and placed in a lab dish, the cells matured into progenitor cells. That shift created a problem because mature cells … Continue reading Muscle stem cells a step closer to treating muscular dystrophy